These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 20045402

  • 1. Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma.
    Kowalska M, Druzd-Sitek A, Fuksiewicz M, Kotowicz B, Chechlinska M, Syczewska M, Walewski J, Kaminska J.
    Clin Biochem; 2010 Apr; 43(6):604-8. PubMed ID: 20045402
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Type I collagen metabolites as tumor markers in patients with lung carcinoma.
    Kobayashi T, Gabazza EC, Taguchi O, Risteli J, Risteli L, Kobayashi H, Yasui H, Yuda H, Sakai T, Kaneda M, Adachi Y.
    Cancer; 1999 May 01; 85(9):1951-7. PubMed ID: 10223235
    [Abstract] [Full Text] [Related]

  • 4. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Racadot A, Boersma A, Delcambre B.
    Rev Rhum Engl Ed; 1997 Mar 01; 64(3):153-9. PubMed ID: 9090763
    [Abstract] [Full Text] [Related]

  • 5. Effect of age-related chronic immobility on markers of bone turnover.
    Chen JS, Cameron ID, Cumming RG, Lord SR, March LM, Sambrook PN, Simpson JM, Seibel MJ.
    J Bone Miner Res; 2006 Feb 01; 21(2):324-31. PubMed ID: 16418789
    [Abstract] [Full Text] [Related]

  • 6. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun 01; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 7. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
    Koizumi M, Yonese J, Fukui I, Ogata E.
    J Urol; 2002 Apr 01; 167(4):1863-6. PubMed ID: 11912449
    [Abstract] [Full Text] [Related]

  • 8. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
    Tähtelä R, Thölix E.
    Anticancer Res; 1996 Apr 01; 16(4B):2289-93. PubMed ID: 8694558
    [Abstract] [Full Text] [Related]

  • 9. Cross-sectional evaluation of bone metabolism in men.
    Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD.
    J Bone Miner Res; 2001 Sep 01; 16(9):1642-50. PubMed ID: 11547833
    [Abstract] [Full Text] [Related]

  • 10. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
    Alexandrakis MG, Passam FH, Sfiridaki A, Kandidaki E, Roussou P, Kyriakou DS.
    Am J Hematol; 2003 Apr 01; 72(4):229-33. PubMed ID: 12666132
    [Abstract] [Full Text] [Related]

  • 11. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 12. Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma.
    Alexandrakis MG, Sfiridaki A, Miyakis S, Pappa C, Kandidaki E, Alegakis A, Margioris AN.
    Clin Chim Acta; 2007 Apr 15; 379(1-2):31-5. PubMed ID: 17234170
    [Abstract] [Full Text] [Related]

  • 13. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B.
    J Rheumatol; 1998 Dec 15; 25(12):2339-44. PubMed ID: 9858427
    [Abstract] [Full Text] [Related]

  • 14. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.
    Reginster JY, Sarkar S, Zegels B, Henrotin Y, Bruyere O, Agnusdei D, Collette J.
    Bone; 2004 Feb 15; 34(2):344-51. PubMed ID: 14962813
    [Abstract] [Full Text] [Related]

  • 15. Serum markers of bone metabolism in dogs.
    Allen MJ, Hoffmann WE, Richardson DC, Breur GJ.
    Am J Vet Res; 1998 Mar 15; 59(3):250-4. PubMed ID: 9522938
    [Abstract] [Full Text] [Related]

  • 16. Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma.
    Abildgaard N, Brixen K, Eriksen EF, Kristensen JE, Nielsen JL, Heickendorff L.
    Haematologica; 2004 May 15; 89(5):567-77. PubMed ID: 15136220
    [Abstract] [Full Text] [Related]

  • 17. Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model.
    Rissanen JP, Suominen MI, Peng Z, Morko J, Rasi S, Risteli J, Halleen JM.
    Calcif Tissue Int; 2008 Feb 15; 82(2):155-61. PubMed ID: 18219436
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of cancer-induced bone diseases by bone metabolic marker].
    Takahashi S.
    Clin Calcium; 2006 Apr 15; 16(4):581- 90. PubMed ID: 16582508
    [Abstract] [Full Text] [Related]

  • 19. Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer.
    Santala M, Simojoki M, Risteli J, Risteli L, Kauppila A.
    Clin Cancer Res; 1999 Dec 15; 5(12):4091-6. PubMed ID: 10632345
    [Abstract] [Full Text] [Related]

  • 20. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
    Kyrtsonis MC, Vassilakopoulos TP, Siakantaris MP, Kokoris SI, Gribabis DA, Dimopoulou MN, Angelopoulou MK, Pangalis GA.
    Eur J Haematol; 2004 Apr 15; 72(4):252-8. PubMed ID: 15089762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.